| Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors KH Lim, A Tefferi, TL Lasho, C Finke, M Patnaik, JH Butterfield, ... Blood, The Journal of the American Society of Hematology 113 (23), 5727-5736, 2009 | 638 | 2009 |
| TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis A Tefferi, A Pardanani, KH Lim, O Abdel-Wahab, TL Lasho, J Patel, ... Leukemia 23 (5), 905-911, 2009 | 531 | 2009 |
| Association of HLA class I with severe acute respiratory syndrome coronavirus infection M Lin, HK Tseng, JA Trejaut, HL Lee, JH Loo, CC Chu, PJ Chen, YW Su, ... BMC medical genetics 4, 1-7, 2003 | 389 | 2003 |
| Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML A Tefferi, KH Lim, O Abdel-Wahab, TL Lasho, J Patel, MM Patnaik, ... Leukemia 23 (7), 1343-1345, 2009 | 316 | 2009 |
| Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates A Tefferi, RL Levine, KH Lim, O Abdel-Wahab, TL Lasho, J Patel, ... Leukemia 23 (5), 900-904, 2009 | 283 | 2009 |
| Cytoreductive therapy in 108 adults with systemic mastocytosis: Outcome analysis and response prediction during treatment with interferon‐alpha, hydroxyurea, imatinib mesylate … KH Lim, A Pardanani, JH Butterfield, CY Li, A Tefferi American journal of hematology 84 (12), 790-794, 2009 | 220 | 2009 |
| Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies A Pardanani, KH Lim, TL Lasho, C Finke, RF McClure, CY Li, A Tefferi Blood, The Journal of the American Society of Hematology 114 (18), 3769-3772, 2009 | 189 | 2009 |
| Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer RK Hsieh, KH Lim, HT Kuo, CY Tzen, MJ Huang Chest 128 (1), 317-321, 2005 | 144 | 2005 |
| WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults A Pardanani, KH Lim, TL Lasho, CM Finke, RF McClure, C Li, A Tefferi Blood, The Journal of the American Society of Hematology 115 (1), 150-151, 2010 | 94 | 2010 |
| Mutation in TET2 in myeloid cancers. A Tefferi, KH Lim, R Levine The New England journal of medicine 361 (11), 1117; author reply 1117-8, 2009 | 77 | 2009 |
| Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors KH Lim, MJ Huang, LT Chen, TE Wang, CL Liu, CS Chang, MC Liu, ... Medical oncology 25, 207-213, 2008 | 58 | 2008 |
| KIT and Mastocytosis KH Lim, A Pardanani, A Tefferi Acta Haematologica 119 (4), 194-198, 2008 | 49 | 2008 |
| Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms YC Chang, HC Lin, YH Chiang, CGS Chen, L Huang, WT Wang, ... Medical Oncology 34, 1-6, 2017 | 46 | 2017 |
| NKG2A down-regulation by dasatinib enhances natural killer cytotoxicity and accelerates effective treatment responses in patients with chronic myeloid leukemia MC Chang, HI Cheng, K Hsu, YN Hsu, CW Kao, YF Chang, KH Lim, ... Frontiers in Immunology 9, 3152, 2019 | 39 | 2019 |
| Epidermal growth factor induces STAT1 expression to exacerbate the IFNr‐mediated PD‐L1 axis in epidermal growth factor receptor‐positive cancers CC Cheng, HC Lin, KJ Tsai, YW Chiang, KH Lim, CGS Chen, YW Su, ... Molecular Carcinogenesis 57 (11), 1588-1598, 2018 | 39 | 2018 |
| Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis KH Lim, YC Chang, C Gon-Shen Chen, HC Lin, WT Wang, YH Chiang, ... Blood cancer journal 5 (3), e295-e295, 2015 | 38 | 2015 |
| YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells CC Cheng, J Chang, SCC Huang, HC Lin, AS Ho, KH Lim, CC Chang, ... PLoS One 12 (8), e0182149, 2017 | 35 | 2017 |
| Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer CJ Lin, RK Hsieh, KH Lim, HH Chen, YC Cheng, CJ Wu Southern Medical Journal 100 (9), 916-917, 2007 | 34 | 2007 |
| BAFF-driven NLRP3 inflammasome activation in B cells KH Lim, LC Chen, K Hsu, CC Chang, CY Chang, CW Kao, YF Chang, ... Cell death & disease 11 (9), 820, 2020 | 32 | 2020 |
| Hypersensitivity reactions to oxaliplatin: a case report and the success of a continuous infusional desensitization schedule KH Lim, MJ Huang, HC Lin, YW Su, YF Chang, J Lin, MC Chang, ... Anti-Cancer Drugs 15 (6), 605-607, 2004 | 32 | 2004 |
